D. Western Therapeutics Institute, Inc.
Notice of Completion of Acquisition and Cancellation of the 13th Stock Acquisition Rights and Monthly Exercise Status
All 13th-series stock acquisition rights were acquired and canceled. No impact on current period results. For the monthly exercise status, of 40,000 shares granted, 81 shares were exercised, and unexercised rights decreased to 7,938.
Key Figures
- Acquired quantity: 7,938 pieces
- Remaining after cancellation: 0 pieces
- Total amount: 412,776 yen
- Exercise ratio: 0.40%
- Unexercised rights: 7,938 pieces (decreased from 8,338 pieces at the end of the previous month)
AI要約
Completion of Acquisition and Cancellation of Stock Acquisition Rights
Based on the board resolution held on July 15, 2025, the Company acquired and canceled all of the 13th-series stock acquisition rights it had issued. The acquisition date was September 29, 2026; the total acquired quantity was 7,938 pieces at 52 yen per right, totaling 412,776 yen. The number of remaining rights after cancellation is 0 pieces. The Company states there is no impact on the current period's financial results.
Monthly Exercise Status and Outlook
For the month, of the 40,000 shares granted in the target month, 81 shares were exercised, resulting in an exercise ratio of 0.40% relative to granted shares (unexercised rights decreased from 8,338 shares to 7,938 shares). Compliance with exercise restrictions was also noted, and overall the dilution impact on the market is considered limited. Future plans or additional scheduled exercises are stated as Unknown.
D. Western Therapeutics Institute, Inc.
Company overview · Stock price · Financial data · All IR
